-
Company Insights
New![]()
Innovation and Patenting activity of Paladin Energy Ltd Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Paladin Energy Ltd Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Analyst Opinions
![]()
Code to Capital – Generative AI Meets Financial Services
Generative AI in Financial Services Report Overview The upsurge in Generative AI (GenAI) centric news, transactions, and company filings within financial services indicates a sector-wide recognition of the technology’s transformative potential. Refining every link in the retail banking value chain, GenAI can amplify personalization, optimize operations, and enhance security, resulting in a holistic transformation of the financial services market. In the front office, Generative AI can facilitate customer interactions across various touchpoints and enable more personalized, efficient user experiences through...
-
Company Profile
![]()
Paladin Energy Ltd – Company Profile
Paladin Energy Ltd (Paladin) is a mineral exploration company. It carries out the acquisition, exploration, and development of uranium projects. The company operates various uranium projects and licences in Australia, Canada, and Africa. The company essentially focuses on its flagship property Langer Heinrich Mine in Namibia, Africa. Its other uranium project portfolio includes Manyingee deposit, and Michelin project. As of June 2022, Langer Heinrich Mine had proven reserves of 48.3 million tonnes (Mt) containing 52 million pounds (mlbs) of uranium...
Add to Basket -
Sector Analysis
![]()
Saudi Arabia Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
Saudi Arabia Defense Market Report Overview The Saudi Arabia defense budget is estimated to be $69.1 billion in 2023 and is expected to achieve a CAGR of more than 4% during 2024-2028. Saudi Arabia's future defense expenditure is driven by national security concerns, regional power dynamics, military modernization, defense partnerships, energy infrastructure protection, and regional instability in the Middle East. Saudi Arabia Defense Market Outlook, 2023-2028 ($ Billion) To gain more information about the Saudi Arabia defense market forecast, download...
-
Analyst Opinions
![]()
Text-to-X – How ChatGPT and Generative AI can Transform the Future of Business
Accessing in-depth insights from the ‘Text-to-X – How ChatGPT and Generative AI can Transform the Future of Business’ report will offer you: Innovation examples by each use case segment of various sectors to present key trends. Real-world innovation use cases and examples related to the implementation of ChatGPT and generative AI by companies across sectors. How generative AI-enabled innovations are developing use cases that are helping enterprises across different sectors. How is the report different from other reports in the market?...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – octreotide acetate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry octreotide acetate Drug Details Octreotide acetate (Octreotide SDI, GP-02) is under development for the...
-
Sector Analysis
![]()
Acromegaly and Gigantism – Global Drug Forecast and Market Analysis to 2029
Acromegaly and gigantism are rare disorders of the pituitary gland characterized by the hypersecretion of growth hormone (GH). This GH excess is often a result of a benign GH-secreting pituitary adenoma. Rarely, tumors in other organs can secrete growth hormone-releasing hormone (GHRH), leading to elevation in GH levels in the serum. This triggers the release of anti-apoptotic and mitogenic peptide hormone, insulin-like growth factor 1 (IGF-1). While both acromegaly and gigantism are complications of uncontrolled GH levels, the presentation of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.